Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious Study
NCT02237833 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2017-04-27
Summary
The purpose of this study is to reveal if higher doses of vasopressors in septic shock patients correlates with cerebral vasoconstriction and lower cerebral oximetry.
Conditions
- Septic Shock
Sponsors & Collaborators
-
Karl-Andre Wian
lead OTHER
Principal Investigators
-
Karl-Andre Wian, cand.med. · Syekhuset Vestfold HF
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
Countries
- Norway
Study Locations
More Related Trials
-
Comparison of Vasopressin and Other Pressors in Septic Shock
NCT00269685 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Proadrenomedullin and Copeptin in Patients With Septic Shock
NCT03104933 ·Status: COMPLETED
-
Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
NCT05833607 ·Status: UNKNOWN
-
Discontinuation Order of Vasopressors in Septic Shock
NCT01493102 ·Status: TERMINATED ·Phase: NA
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
NCT06471231 ·Status: RECRUITING ·Phase: PHASE4
-
The Effect of Increasing the Mean Arterial Pressure on the Microcirculation and the Prognosis of Patients With Septic Shock
NCT04136080 ·Status: UNKNOWN ·Phase: NA
-
Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock
NCT06125184 ·Status: RECRUITING ·Phase: NA
-
Systematic Adjunction of Vasopressine in Septic Shock
NCT07052084 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699 ·Status: COMPLETED ·Phase: PHASE4
-
Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock Therapy
NCT01877798 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
NCT06122987 ·Status: RECRUITING ·Phase: PHASE4
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Continuous Infusion of Terlipressin in Septic Shock
NCT00481572 ·Status: COMPLETED ·Phase: PHASE2
-
Critical Closing Pressure and PCO₂ Gap in Fluid Resuscitation for Septic Shock
NCT07043192 ·Status: ACTIVE_NOT_RECRUITING
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Accuracy in Sepsis
NCT03956043 ·Status: COMPLETED
-
Early Vasopressors in Sepsis
NCT05179499 ·Status: RECRUITING ·Phase: PHASE3
-
Terlipressin in Septic Shock: Effects on Microcirculation
NCT00995839 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hypotension in the Weaning From Vasopressor Drugs
NCT05506319 ·Status: COMPLETED ·Phase: PHASE4
-
Midodrine Use in Septic Shock
NCT03706053 ·Status: TERMINATED ·Phase: PHASE3
-
The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock
NCT02453425 ·Status: COMPLETED ·Phase: NA
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
NCT06709573 ·Status: RECRUITING ·Phase: PHASE4
-
NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
NCT02454348 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
NCT06234592 ·Status: RECRUITING ·Phase: NA